Where the Pet Tech Money Is Actually Going

Pet tech raised $1.2 billion in 2025, up 103 percent year over year. The number sits below the $2.1 billion peak of 2021, and that gap matters more than the headline. Capital came back in 2025, but the money is asking different questions than it did four years ago. The companies attracting it are the ones with answers.

For operators running a clinic, a brand, or a multi-location services platform, the deployment pattern is the most reliable read on where the next two years go. Capital allocation tracks investor conviction more honestly than market-size projections do.

A Bigger Market, Pickier Money

The global pet tech market sits between $17.65 billion and $19.98 billion in 2025, depending on which analyst draws the boundary. Conservative 2031 projections cluster near $27 billion. Bullish ones reach $50 billion by 2034, at compound annual growth rates between 5.8 and 10.9 percent. The number itself is not the story. The story is what the money started asking for in 2024 and 2025.

In 2024, pet tech raised roughly $890 million across all categories. In 2025, that figure hit $1.2 billion. More capital, deployed with more discipline. Compare with the 2020 to 2021 era, when Rover, Wag, and Chewy scaled by accepting negative unit economics in exchange for share. That playbook is dead. Investors now ask for profitability timelines, customer lifetime value calculations, and evidence that the core model works before writing a growth check.

That discipline reshapes which categories attract capital. The hierarchy is now legible.

Vet Clinic Networks Are Where the Money Concentrates

Forty percent of capital flowing to the top fifteen pet tech companies in 2025 went to veterinary clinic networks. The concentration is not coincidence. Clinic networks deliver what consumer pet apps could not: recurring revenue from a customer who comes because their pet is sick, stays for years because the relationship is professional, and generates lifetime value that builds rather than decays.

Modern Animal hit $100 million in annual recurring revenue in 2025, the proof point investors needed for the membership veterinary model. The company has raised $210 million total, including a $46 million Series D in September 2025. Bond Vet runs a different structure, a venture-backed owned-and-operated chain of 50 clinics, but the unit economics are the same flavor: more than one million visits processed, 440,000 pets served, Net Promoter Scores above 90. Consumer pet platforms typically sit in the 50s. When the customer relationship is mediated by a veterinarian, retention is a feature, not a metric you optimize toward.

Small Door Veterinary closed a $55 million equity-and-debt round in July 2025. The data point that mattered to investors was not membership count but the economics of those memberships, specifically whether members upgraded to higher-tier services and stuck around long enough to amortize the acquisition. They do.

The structural reason capital concentrates here becomes clear when set against consumer pet apps. A consumer app spends $30 to $50 to acquire a customer and tries to recoup it through $5 to $15 in monthly subscription value. The math is punishing, and when growth slows the model breaks. Clinic networks invert the equation. Acquisition is effectively zero because the customer arrives needing care. The clinic captures that relationship, layers in digital tools, membership tiers, and data analytics, and lifetime value compounds. Vet clinic unit economics are the durable version of what consumer apps spent ten years pretending to build.

Pet Wearables Have a Hardware Problem, Not a Market Problem

The pet wearables category sits at $7.1 billion in 2025, with projections to $21.8 billion by 2035 at 10.9 percent CAGR. Capital is flowing, but it is flowing to a specific kind of company.

PETKIT, the Chinese hardware manufacturer with U.S. distribution, used CES 2026 to announce an integrated AI ecosystem that connects feeders, water fountains, activity monitors, and health dashboards into a single platform. The announcement signals where hardware companies place their bets in 2026. Not on the device. On the data layer above the device.

The shift reframes how wearable companies think about profitability. First-generation wearable companies treated the collar as the product, with software as an afterthought. Second-generation wearables treat the collar as a customer-acquisition mechanism for a recurring software business. Revenue comes from health-insight subscriptions, integration with veterinary records, and eventually interventions a system can recommend before an owner notices something is wrong. The hardware companies still trying to perfect a smarter collar are finding capital scarce. The ones building a defensible data product on top of cheap hardware are getting funded. The deeper wearables breakdown tracks the specific players and their data-moat strategies.

Practice Management Is the Boring Bet That Pays

Practice management software, veterinary telemedicine, and integrated electronic health records sit below the headlines. They also sit above the noise. Capital flowing into this layer reflects a thesis any operator can read in five seconds: clinics depend on this software to function, switching costs are extreme, churn is minimal, and customer acquisition costs are low because most adoption happens through referrals.

Vetster handles the telemedicine wedge. Shepherd Veterinary Software builds integrated practice management. Various point solutions address narrower pain points around scheduling, inventory, and staff communication. None of these companies generate the kind of growth narrative that wins TechCrunch coverage. They generate the kind of net revenue retention that wins later-stage rounds.

A practice management vendor charging $1,000 to $5,000 per clinic per month, depending on clinic size, retains that clinic for an average of four to seven years. Lifetime value lands between $48,000 and $420,000 per account. Multiply that by even a few thousand clinics and the model produces serious cash flow without the marketing burn that consumer pet tech requires. Capital in 2025 flowed to operators in this space who could demonstrate both breadth across clinic operations and depth integrating with adjacent services. The trajectory is consolidation, with larger platforms acquiring point solutions to offer clinics one ecosystem rather than a stack of tools.

The Vetted Capital Pivot Tells You What Changed

The clearest signal of the discipline shift is what happened to a fund built specifically to back pet tech. Vetted Capital launched in 2023 targeting $150 million to $300 million for early-stage pet tech investments. By September 2025, the firm had restructured. The traditional fund model gave way to a deal-by-deal investment approach.

This is not a retreat from the sector. It is a professionalization. The fund's principals concluded that pet tech, even at its best, did not produce enough opportunities at scale to justify a blind-pool fund. Capital should be deployed selectively, with deeper diligence and clearer operational milestones. The questions that should always have been asked, finally got asked.

For operators, the implication is direct. If you are building a vet network with provable unit economics, expect a faster path to capital and more competitive valuations. If you are building a consumer app, expect a longer fundraising cycle and higher pressure to demonstrate either profitability or a credible path to it within twelve to eighteen months. The current investor-by-stage map makes the same point with names attached.

"The fund's principals concluded that pet tech, even at its best, did not produce enough opportunities at scale to justify a blind-pool fund."

The Consolidation Plays Are Getting Bigger

Beneath the company-by-company stories runs a structural shift. Pet tech capital in 2025 and 2026 flows heavily toward acquirers, not just operators. Mars Veterinary Health now reaches more than 10 million pet visits annually across its acquired clinic portfolio. The capability to integrate practice management systems, negotiate supply pricing, and run a unified loyalty program across thousands of locations is what large corporate buyers are paying for.

For independent clinics, the trend cuts both ways. Clinics with strong unit economics, patient loyalty, and a growth trajectory will field acquisition offers. Clinics on thin margins without digital infrastructure or membership economics will face networks with structural pricing leverage they cannot match. The decision to sell, partner, or stay independent is now a strategic question, not a personal one.

The same dynamic is playing out one tier up at the platform level. The 41 percent year-over-year increase in pet industry deal volume in 2025 is concentrated in services, software, and platform companies, not in product brands. The buyers know what they want, and pet tech is squarely in the middle of it.

What Operators Should Watch

Five signals to monitor across 2026. Most read off the same trend.

Membership economics are the price of entry. Vet clinics, services platforms, and even DTC brands without a recurring-revenue option will trade at structural discounts to peers that have one. The companies cited in this article, Modern Animal, Small Door, Bond Vet, are not anomalies. They are the model.

Data integration is becoming the moat. Wearables, EHR, practice management, and telemedicine are converging into a single operational data layer. Operators who invest now in systems that talk to each other will compound advantages over operators who run siloed stacks. The AI applications worth funding all sit on top of this integrated data layer, not on standalone consumer apps.

Acquisition offers will arrive sooner than expected. Profitable, well-operated services businesses with sticky customers should expect inbound interest from PE platforms and corporate strategics throughout 2026. The multiples are no longer 2021 multiples, but they are real, and the strategic question of when to engage is getting harder to defer.

Consumer apps will keep losing. Standalone pet apps without B2B buyers, hardware moats, or veterinary integration will continue to struggle for capital. Founders pitching consumer engagement metrics should expect a ten-minute conversation, not a term sheet.

Telemedicine will not become the bulk of vet visits. The capital flowing to this segment in 2026 is real but bounded. Operators should treat telemedicine as a complement bundled with in-person care, not a primary revenue channel.

The pet tech landscape stopped being a speculative frontier somewhere between the Vetted Capital pivot and the Modern Animal $100M ARR announcement. It is now an operational business with rules, comparables, and durable winners. Operators who treat it that way will hold the capital, the customers, and the strategic optionality. The ones still pitching vanity metrics will find rooms emptying faster than they expected.